Sermorelin
Stimulates the GHRH receptor in the pituitary. It was once approved for children with growth hormone deficiency; studies in adults are small and limited.
Investigational · not currently FDA-approved
Educational information about two growth-hormone secretagogues, their limits, their risks and their regulatory status.
Introduction
Ipamorelin and sermorelin are two synthetic peptides that act on the pituitary gland, which controls the release of growth hormone. Some compounding pharmacies prepare them together.
This page explains what is known and what is not. The combination is not an FDA-approved product, and its benefits have not been established in people. Any decision starts with a medical evaluation.
Overview
Sermorelin is a synthetic form of part of growth hormone-releasing hormone (GHRH), the signal the brain uses to tell the pituitary gland to release growth hormone.
Ipamorelin is a synthetic peptide that acts on a different receptor, the ghrelin (growth hormone secretagogue) receptor, which can also trigger growth hormone release. The two act through different pathways, which is the theoretical reason they are combined; the combination itself has not been studied in clinical trials.
Mechanisms
Stimulates the GHRH receptor in the pituitary. It was once approved for children with growth hormone deficiency; studies in adults are small and limited.
Activates the ghrelin receptor and raised growth hormone in early studies. It has never been approved, and human data are limited.
Research
Growth hormone secretagogues have been studied for age-related changes in growth hormone, body composition and recovery. In healthy adults, results are inconsistent, and raising growth hormone or IGF-1 levels has not been shown to improve health, strength or longevity.
Next step
If you are concerned about energy, body composition or hormones, a medical evaluation helps identify proven options.
Limitations
No FDA-approved product contains both peptides.
Effects of use over months or years are unknown.
A rise in growth hormone does not mean better health.
Compounded products are not reviewed like approved drugs.
Risks
Seek urgent care for signs of a severe allergic reaction, such as swelling or difficulty breathing.
Redness, swelling or itching.
Usually temporary.
Reported with growth hormone effects.
Growth hormone can reduce insulin sensitivity.
Including effects of sustained higher IGF-1.
Uncommon but possible.
Safety
These peptides may not be appropriate if any of the following apply to you:
Evaluation
Your symptoms, conditions, medications and expectations.
Such as IGF-1 or blood sugar, to look for a cause.
Diagnosed conditions are treated with approved options.
Follow-up
If a provider prescribes any treatment, follow-up is individualized.
Reviewed at each visit.
Checked when indicated.
To avoid levels that are too high.
Treatment is stopped if there is no clear benefit.
Regulatory status
Sermorelin was once FDA-approved for children with growth hormone deficiency; the manufacturer stopped producing it in 2008 for reasons not related to safety, and no approved sermorelin product is currently marketed in the U.S.
Ipamorelin has never been FDA-approved, and the FDA has identified safety concerns about its use in compounded drugs. The ipamorelin + sermorelin combination is not an FDA-approved product. Growth hormone secretagogues are prohibited in competitive sport.
FAQ
Clear answers to help you prepare.
No. The combination is not an FDA-approved product. Sermorelin was approved in the past for children with growth hormone deficiency, but that product is no longer marketed, and ipamorelin has never been approved.
These effects have not been established in clinical studies of this combination. Your provider can discuss proven options for your goals.
No. Raising growth hormone has not been shown to slow aging or extend life, and long-term safety is unknown.
Growth hormone secretagogues are prohibited in competitive sport, including out of competition.
Any medicine, dose, route and schedule are decided only by a licensed provider after an individual evaluation. This page is educational and does not give treatment instructions.
Information on this page is educational and does not replace medical evaluation. Treatment options are determined individually.